MIRA
INFORM REPORT
|
Report Date : |
26.06.2008 |
IDENTIFICATION
DETAILS
|
Name : |
IKEDA SCIENTIFIC CO LTD |
|
|
|
|
Registered Office : |
Kanda KS Bldg, 1-8-6 Kajicho Chiyodaku Tokyo 101-0044 |
|
|
|
|
Country : |
Japan |
|
|
|
|
Financials (as on) : |
31.03.2008 |
|
|
|
|
Date of Incorporation : |
July 1947 |
|
|
|
|
Legal Form : |
Limited Company (Kabushiki Kaisha) |
|
|
|
|
Line of Business : |
Import of Biochemical Equipment |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
YEN 747.2 Million |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
name & address
IKEDA SCIENTIFIC
CO LTD
REGD NAME: KK Ikeda Rika
MAIN OFFICE: Kanda KS Bldg, 1-8-6 Kajicho Chiyodaku Tokyo
101-0044 JAPAN
Tel:
03-5256-1818 Fax: 03-5256-1818
URL: http://www.ikedarika.co.jp/
E-Mail address:contact@ikedarika.co.jp
ACTIVITIES
Import of biochemical equipment
BRANCHES
Hachioji, Hiratsuka, Mishima, Ichihara, Yokohama, Kobe,
other (Tot 12)
OFFICER(S)
TAMIO KIZAKI, PRES
Masami Ikeda, s/mgn dir
Hirokazu Kitamura, mgn dir
Shigeo Mizuno, dir
Yen Amount: In
million Yen, unless otherwise stated
SUMMARY
FINANCES FAIR A/SALES Yen 30,517 M
PAYMENTS REGULAR CAPITAL Yen 50 M
TREND STEADY WORTH Yen 6,591 M
STARTED 1947 EMPLOYES 256
COMMENT
TRADING FIRM SPECIALIZING IN BIOCHEMICAL EQUIPMENT.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY
BUSINESS ENGAGEMENTS.
MAX CREDIT LIMIT
YEN 747.2 MILLION, 30 DAYS NORMAL TERMS
HIGHLIGHTS
The subject company was established Taizo Ikeda in order to make most of his experience in the subject line of business. Originally manufactures these goods but later changed the business line to a trading firm specializing in scientific equipment and biochemical instruments. Acts as import agent for Bio Dot (USA), Partec (Germany), Bio Robotics (UK), other. Clients include government agencies.
FINANCIAL INFORMATION
The sales volume for Mar/2008 fiscal term amounted to Yen 30,517 million, a similar amount in the previous term. The recurring profit was posted at Yen 906 million and the net profit at Yen 510 million, respectively, compared with Yen 736 million recurring profit ant Yen 338 million net profit, respectively, a year ago.
For the current term ending Mar 2009 the net profit is projected at Yen 520 million, on a 5% rise in turnover, to Yen 52,000 million.
The financial situation is considered FAIR and good for ORDINARY business engagements. Max credit limit is estimated at Yen 747.2 million, on 30 days normal terms.
REGISTRATION
Date Registered: Jul 1947
Legal Status: Limited Company (Kabushiki Kaisha)
Authorized: 4 million shares
Issued: 1 million shares
Sum: Yen 50 million
Major shareholders (%)
Hiroko Shibazaki (50), Motoo Hirose (4), Tamio Kizaki (2)
No. of shareholders: 50
Nothing detrimental is known as to the commercial morality of executives.
OPERATION
Activities: Trading firm for import, export and wholesale of scientific & biochemical equipment & instruments: flow meter, microbial detection, liquid handling, high-precision bio instrumentation DNA & protein purification system, pipetting instruments, other (--100%).
Clients
[Government agencies, wholesalers] Ministry of Economy, Trade & Transport, Ministry of Environment, Ministry of Education, Culture, Sports Science and Technology, Ministry of Agriculture, Ministry of Health, Labour & Welfare, other.
No. of accounts: 500
Domestic areas of activities: Nationwide
Suppliers
[Mfrs, wholesalers] Applied Bio-Systems Japan, Hitachi Hi-Technologies, Fuji Film, GE Healthcare Bio-Science, Sanyo Electric, Nippon Becton Dickinson, other.
Payment record
Regular
Location
Business area in Tokyo. Office premises at the caption address are leased and maintained satisfactorily.
Bank References
SMBC (Nihombashi)
SMBC (Ohdenmacho)
Relations: Satisfactory
FINANCES: (In Million Yen)
|
Terms Ending: |
31/03/2009 |
31/03/2008 |
31/03/2007 |
31/03/2006 |
|
|
Annual
Sales |
|
32,000 |
30,517 |
30,256 |
30,262 |
|
Recur.
Profit |
|
|
906 |
736 |
|
|
Net
Profit |
|
520 |
510 |
338 |
356 |
|
Total
Assets |
|
|
20,616 |
18,730 |
|
|
Current
Assets |
|
|
16,718 |
14,784 |
|
|
Current
Liabs |
|
|
13,624 |
12,512 |
|
|
Net
Worth |
|
|
6,591 |
6,118 |
|
|
Capital,
Paid-Up |
|
|
50 |
50 |
50 |
|
Div.P.Share(¥) |
|
|
|
|
|
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
4.86 |
0.86 |
-0.02 |
7.08 |
|
|
Current Ratio |
|
.. |
122.71 |
118.16 |
.. |
|
N.Worth Ratio |
.. |
31.97 |
32.66 |
.. |
|
|
R.Profit/Sales |
|
.. |
2.97 |
2.43 |
.. |
|
N.Profit/Sales |
1.63 |
1.67 |
1.12 |
1.18 |
|
|
Return On Equity |
.. |
7.74 |
5.52 |
.. |
|
Notes: Forecast (or estimated) figures for the 31/03/2009
fiscal term.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.42.79 |
|
UK Pound |
1 |
Rs.85.04 |
|
Euro |
1 |
Rs.67.39 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)